Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel K Hoyles

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Clinical Medicine (London, England)|February 3, 2016
Therapeutic advances in idiopathic pulmonary fibrosisEmily Fraser, Rachel K Hoyles
BMJ Open Respiratory Research|June 13, 2020
Readily accessible CT scoring method to quantify fibrosis in IPFEmily Fraser, Victoria St Noble, Rachel K Hoyles, et al.
BMJ Open Respiratory Research|October 10, 2023
Neutrophil levels correlate with quantitative extent and progression of fibrosis in IPF: results of a single-centre cohort studyAndrew Achaiah, Emily Fraser, Peter Saunders, et al.
The Journal of Investigative Dermatology|June 20, 2008
Inducible lineage-specific deletion of TbetaRII in fibroblasts defines a pivotal regulatory role during adult skin wound healingChristopher P Denton, Korsa Khan, Rachel K Hoyles, et al.
BMJ Open Respiratory Research|November 20, 2021
Monocyte and neutrophil levels are potentially linked to progression to IPF for patients with indeterminate UIP CT patternAndrew Achaiah, Amila Rathnapala, Andrea Pereira, et al.
BMJ Open Respiratory Research|June 17, 2022
Neutrophil lymphocyte ratio as an indicator for disease progression in Idiopathic Pulmonary FibrosisAndrew Achaiah, Amila Rathnapala, Andrea Pereira, et al.
American Journal of Respiratory and Critical Care Medicine|August 17, 2010
An essential role for resident fibroblasts in experimental lung fibrosis is defined by lineage-specific deletion of high-affinity type II transforming growth factor β receptorRachel K Hoyles, Emma C Derrett-Smith, Korsa Khan, et al.
Advances in Therapy|October 27, 2015
Development of a Consensus Statement for the Definition, Diagnosis, and Treatment of Acute Exacerbations of Idiopathic Pulmonary Fibrosis Using the Delphi TechniqueToby M Maher, Moira K B Whyte, Rachel K Hoyles, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 21, 2017
Short-Term Pulmonary Function Trends Are Predictive of Mortality in Interstitial Lung Disease Associated With Systemic SclerosisNicole S Goh, Rachel K Hoyles, Christopher P Denton, et al.
Arthritis Research & Therapy|September 7, 2021
The pan-PPAR agonist lanifibranor reduces development of lung fibrosis and attenuates cardiorespiratory manifestations in a transgenic mouse model of systemic sclerosisEmma Derrett-Smith, Kristina E N Clark, Xu Shiwen, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Clinical Medicine (London, England)|February 3, 2016
Therapeutic advances in idiopathic pulmonary fibrosisEmily Fraser, Rachel K Hoyles
BMJ Open Respiratory Research|June 13, 2020
Readily accessible CT scoring method to quantify fibrosis in IPFEmily Fraser, Victoria St Noble, Rachel K Hoyles, et al.
BMJ Open Respiratory Research|October 10, 2023
Neutrophil levels correlate with quantitative extent and progression of fibrosis in IPF: results of a single-centre cohort studyAndrew Achaiah, Emily Fraser, Peter Saunders, et al.
The Journal of Investigative Dermatology|June 20, 2008
Inducible lineage-specific deletion of TbetaRII in fibroblasts defines a pivotal regulatory role during adult skin wound healingChristopher P Denton, Korsa Khan, Rachel K Hoyles, et al.
BMJ Open Respiratory Research|November 20, 2021
Monocyte and neutrophil levels are potentially linked to progression to IPF for patients with indeterminate UIP CT patternAndrew Achaiah, Amila Rathnapala, Andrea Pereira, et al.
BMJ Open Respiratory Research|June 17, 2022
Neutrophil lymphocyte ratio as an indicator for disease progression in Idiopathic Pulmonary FibrosisAndrew Achaiah, Amila Rathnapala, Andrea Pereira, et al.
American Journal of Respiratory and Critical Care Medicine|August 17, 2010
An essential role for resident fibroblasts in experimental lung fibrosis is defined by lineage-specific deletion of high-affinity type II transforming growth factor β receptorRachel K Hoyles, Emma C Derrett-Smith, Korsa Khan, et al.
Advances in Therapy|October 27, 2015
Development of a Consensus Statement for the Definition, Diagnosis, and Treatment of Acute Exacerbations of Idiopathic Pulmonary Fibrosis Using the Delphi TechniqueToby M Maher, Moira K B Whyte, Rachel K Hoyles, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 21, 2017
Short-Term Pulmonary Function Trends Are Predictive of Mortality in Interstitial Lung Disease Associated With Systemic SclerosisNicole S Goh, Rachel K Hoyles, Christopher P Denton, et al.
Arthritis Research & Therapy|September 7, 2021
The pan-PPAR agonist lanifibranor reduces development of lung fibrosis and attenuates cardiorespiratory manifestations in a transgenic mouse model of systemic sclerosisEmma Derrett-Smith, Kristina E N Clark, Xu Shiwen, et al.
Pageof 2